American College of Cardiology

AUGUST 29, 2024

The following are key points to remember from a state-of-the-art review on cardiovascular disease (CVD) assessment and management in liver transplantation.

Transplant 40

Transplant Cardiovascular Disease Article 40

Circulation

MARCH 11, 2024

Hematopoietic stem cell transplantation can cure various disorders but poses cardiovascular risks, especially for elderly patients and those with cardiovascular diseases. Cardiovascular evaluations are crucial in pretransplantation assessments, but guidelines are lacking.

Transplant 45

Transplant Cardiovascular Disease Atrial Fibrillation Pediatrics 45

DAIC

APRIL 30, 2024

Image courtesy of Hideki Kobayashi from Shinshu University milla1cf Tue, 04/30/2024 - 12:53 April 30, 2024 — Regenerative heart therapies involve transplanting cardiac muscle cells into damaged areas of the heart to recover lost function. However, the risk of arrhythmias following this procedure is reportedly high.

Transplant 105

Transplant Heart Transplant Myocardial Infarction Heart Attack 105

Journal of the American Heart Association

DECEMBER 12, 2023

BackgroundScreening for cardiovascular disease is currently recommended before kidney transplantation. Patients recommended cardiology referral or cardiac screening had a higher risk of major adverse cardiovascular events (hazard ratio [HR], 5.5 [95% Journal of the American Heart Association, Ahead of Print. 95% [CI, 4.6–31.4];

Transplant 40

Transplant Heart Disease Cardiovascular Disease Outcomes 40

DAIC

FEBRUARY 2, 2024

Course Chairs are: Ana Barac, MD, PhD, FACC , Inova Health System ; and Bonnie Ky, MD, MSCE, FACC , University of Pennsylvania, Perelman School of Medicine. Course Vice Chair is Richard Cheng, MD, MSc, FACC , University of Washington.

Cardio Oncology 95

Cardio Oncology Cancer Pharmacology RN 95

Circulation

NOVEMBER 11, 2024

However, the assessment of aerobic capacity in this population still relies on comparisons with people without cardiovascular disease, rather than comparison with the expected aerobic capacity of other Fontan patients. 1.28, p=0.02), and 4thquartile were associated with a higher risk of death/transplant (HR 1.32, 95% CI 1.16-1.69,

Transplant 40

Transplant Outcomes Exercise Cardiovascular Disease 40

Cardiometabolic Health Congress

AUGUST 8, 2024

Cardiometabolic risk encompasses a complex spectrum of interrelated conditions, including cardiovascular disease, type 2 diabetes, and metabolic syndrome.

Education 59

Education Cardiovascular Disease Diabetes Kidney Disease 59

Circulation

FEBRUARY 15, 2024

BACKGROUND:Clonal hematopoiesis of indeterminate potential (CHIP), a common age-associated phenomenon, associates with increased risk of both hematological malignancy and cardiovascular disease.

Atrial Fibrillation 45

Atrial Fibrillation Diet Myocardial Infarction Cardiovascular Disease 45

Society of Thoracic Surgeons - Research

MAY 5, 2023

Engaging editorials, focused mini-reviews, educational and impactful case reports, “how to do it” technique papers, and images in cardiothoracic surgery are featured.

Article 40

Article Cardiothoracic Education Congenital 40

Cardiology Update

APRIL 9, 2024

Investigators assessed if empagliflozin could lower the risk of hospitalization for heart failure (HF) or death from cardiovascular disease (CVD). The primary endpoint was a composite of all-cause mortality, left ventricular assist device (LVAD)/heart transplantation, HF hospitalizations, worsening HF, and KCCQ score changes.

Angina 52

Angina Myocardial Infarction Aortic valve Coronary Artery Disease 52

Circulation

NOVEMBER 11, 2024

Background:Immunosuppressive (IS) therapy is currently used as first-line treatment for heart transplant (HTx) rejection. Circulation, Volume 150, Issue Suppl_1 , Page A4139383-A4139383, November 12, 2024. However, they are not without complications, and less toxic therapies are needed. years, males: 58.4%).

Heart Transplant 40

Heart Transplant Transplant Cardiovascular Disease Outcomes 40

Dr. Paddy Barrett

MAY 31, 2024

The prevalence of smoking back in the 1950s would have been much higher, but even recent studies on ‘healthy’ heart transplant donors who died from events such as road traffic accidents still show high rates of very early-stage plaque buildup 4. It is a marker of where someone is on a disease progression pathway.

Heart Disease 94

Heart Disease Plaque Heart Attack Heart attacks 94

Stroke Journal

JANUARY 30, 2025

Initially, CHIP was identified as a risk factor for hematologic cancer, but recently, many studies have implicated it as a risk factor for cardiovascular disease. congenic mice were transplanted with suspensions of bone marrow cells containing 10% CD45.1-/CD45.2+ CHIP is also considered a risk factor for subarachnoid hemorrhage.

Aneurysm 40

Aneurysm Transplant Risk Factors Cancer 40

Journal of the American Heart Association

MARCH 3, 2025

Moderators assessed were sample demographics (age, body mass index, sex, and time since T2D diagnosis) and cardiovascular outcomes (eg, echocardiographic variables, blood pressure).ResultsAbsolute ResultsAbsolute (cohorts n=30; subjects n=1152; mean difference, 0.29 L/min [95% CI, 0.37 mL/kg per min; 95% CI, 6.94

Exercise 45

Exercise Diabetes Bicuspid/Mitral Blood Pressure 45

Cardiometabolic Health Congress

MARCH 8, 2024

Anuradha Lala-Trindade, MD: She focuses on the selection and care of patients with mechanical circulatory support devices and heart transplantation, genetic cardiomyopathies, and perioperative management of high-risk cardiac surgical cases.

Cardiac Rehabilitation 59

Cardiac Rehabilitation Academic Diabetes Research 59

Wellnest

DECEMBER 11, 2023

Blood Transfusions and Organ Transplants: Though rare, the virus can be transmitted through infected blood or organ donations. As beneficial as ART Therapy is, recent studies suggest that INSTIs and CCR5 antagonists exhibit cardiovascular toxicity, raising valid concerns as it can lead to a higher risk of CVDs.

Quality of Life 52

Quality of Life Myocardial Infarction Public Health Arrhythmia 52

Journal of Clinical Investigation - Cardiology

JANUARY 2, 2025

While individuals with CH generally do not show signs of hematologic disease, the condition becomes more common with age and correlates with age-related diseases, especially cardiovascular disease (CVD). In this issue of the JCI, Liu et al.

Plaque 95

Plaque Transplant Atherosclerosis Cardiovascular Disease 95

Journal of Clinical Investigation - Cardiology

JANUARY 16, 2025

Cardiovascular disease (CVD) remains the leading cause of morbidity and mortality worldwide, with inflammation playing a pivotal role in its pathogenesis. Understanding the intricate interplay between T cells and cardiovascular pathology is essential for developing novel immunotherapeutic strategies against CVD.

Heart Transplant 68

Heart Transplant Myocardial Infarction Transplant Cardiovascular Disease 68

Dr. Malcolm Kendrick

OCTOBER 30, 2024

The hypothesis that a raised cholesterol level causes heart disease [atherosclerotic cardiovascular disease (ASCVD)] is possibly the single most powerful idea in medicine. Which remains the single most influential study on cardiovascular disease, ever. At least some of it. It was simply a matter of time.

Cholesterol 145

Cholesterol Article Research Diet 145